The Scientist

» cancer, microbiology and developmental biology

Most Recent

image: HHS Updates Carcinogens List

HHS Updates Carcinogens List

By | October 3, 2014

Four chemicals are added to the official US catalog of potential cancer-causing substances.

1 Comment

image: Speaking of Vision Science

Speaking of Vision Science

By | October 1, 2014

October 2014's selection of notable quotes

1 Comment

image: The Ocular Microbiome

The Ocular Microbiome

By | October 1, 2014

Researchers are beginning to study in depth the largely uncharted territory of the eye’s microbial composition.

0 Comments

image: Soil Microbiome of Central Park

Soil Microbiome of Central Park

By | September 30, 2014

Nearly 600 soil samples from New York City’s famous park reveal that the urban environment harbors just as much biodiversity as natural ecosystems across the globe.

1 Comment

image: Recruiting Anthrax to Oncology

Recruiting Anthrax to Oncology

By | September 26, 2014

In the latest development in trying to use Bacillus anthracis to kill cancer, researchers send “antibody mimics” inside tumor cells.

0 Comments

image: Intensive Loss of Gut Bacteria Diversity

Intensive Loss of Gut Bacteria Diversity

By | September 23, 2014

Lengthy stints in intensive care units pare down patients’ gut microflora, a study shows.

0 Comments

image: Small Molecule Superstore

Small Molecule Superstore

By | September 15, 2014

An analysis of bacterial sequences from the Human Microbiome Project has uncovered thousands of biosynthetic gene clusters.

0 Comments

image: Small Wonders

Small Wonders

By | September 11, 2014

Sangeeta Bhatia, creator of miniature medical technologies, has won the Lemelson-MIT Prize.

0 Comments

image: Watson to Match Patients to Clinical Trials

Watson to Match Patients to Clinical Trials

By | September 8, 2014

IBM’s cognitive computer will be individualizing trial plans for cancer patients at the Mayo Clinic.

0 Comments

image: FDA Gives Nod to Melanoma Drug

FDA Gives Nod to Melanoma Drug

By | September 8, 2014

The US Food and Drug Administration last week approved the first of a new type of immunotherapy that aims to pit a patient’s own immune system against her cancer.

2 Comments

Popular Now

  1. GM Mosquitoes Closer to Release in U.S.
  2. Judge Recommends Ruling to Block Internet Access to Sci-Hub
  3. Opinion: Microbiology Needs More Math
  4. Do Pathogens Gain Virulence as Hosts Become More Resistant?
RayBiotech